STERIS plc Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- STERIS plc payments for repurchase of common stock for the quarter ending 2026-06-30 was $115.50M, a 989.62% increase year-over-year.
- STERIS plc payments for repurchase of common stock for the quarter ending 2026-03-31 was $74.30M, a 37050.00% increase year-over-year.
- STERIS plc payments for repurchase of common stock for the quarter ending 2025-12-31 was $50.10M, a 50.15% decline year-over-year.
- STERIS plc payments for repurchase of common stock for the quarter ending 2025-09-30 was $100.50M, a 116.49% increase year-over-year.
- STERIS plc payments for repurchase of common stock for fiscal 2026 was $235.50M, a 11.45% increase from fiscal 2025.
- STERIS plc payments for repurchase of common stock for fiscal 2025 was $211.30M, a 1690.68% increase from fiscal 2024.
- STERIS plc payments for repurchase of common stock for fiscal 2024 was $11.80M, a 96.18% decline from fiscal 2023.
- STERIS plc payments for repurchase of common stock for fiscal 2023 was $308.56M, a 453.21% increase from fiscal 2022.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $115.50M 10-Q · filed 2026-08-07 | $340.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $74.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $235.50M 10-K · filed 2026-05-29 |
| 2025-12-31 | $50.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $161.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | $100.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $211.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $10.60M 10-Q · filed 2026-08-07 | $157.72M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $211.30M 10-K · filed 2026-05-29 |
| 2024-12-31 | $100.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $211.48M derived: sum of 4 quarters · filed 2026-05-29 |
| 2024-09-30 | $46.42M 10-Q · filed 2024-11-07 | $113.21M derived: sum of 4 quarters · filed 2026-05-29 |
| 2024-06-30 | $64.20M 10-Q · filed 2025-08-07 | $67.28M derived: sum of 4 quarters · filed 2026-05-29 |
| 2024-03-31 | $360.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $11.80M 10-K · filed 2026-05-29 |
| 2023-12-31 | $2.23M 10-Q · filed 2024-02-08 | $166.05M derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-09-30 | $489.00K 10-Q · filed 2024-11-07 | $247.86M derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-06-30 | $8.72M 10-Q · filed 2024-08-08 | $292.61M derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-03-31 | $154.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $308.56M 10-K · filed 2025-05-29 |
| 2022-12-31 | $84.03M 10-Q · filed 2024-02-08 | $182.10M derived: sum of 4 quarters · filed 2024-05-29 |
| 2022-09-30 | $45.24M 10-Q · filed 2023-11-07 | $100.95M derived: sum of 4 quarters · filed 2024-05-29 |
| 2022-06-30 | $24.68M 10-Q · filed 2023-08-08 | $69.79M derived: sum of 4 quarters · filed 2024-05-29 |
| 2022-03-31 | $28.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $55.78M 10-K · filed 2024-05-29 |
| 2021-12-31 | $2.88M 10-Q · filed 2023-02-08 | $27.71M derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-09-30 | $14.08M 10-Q · filed 2022-11-09 | $24.96M derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-06-30 | $10.67M 10-Q · filed 2022-08-08 | $11.02M derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-03-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $14.65M 10-K · filed 2023-05-26 |
| 2020-12-31 | $127.00K 10-Q · filed 2022-02-09 | $25.48M derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-09-30 | $138.00K 10-Q · filed 2021-11-08 | $27.81M derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-06-30 | $14.30M 10-Q · filed 2021-08-09 | $50.65M derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-03-31 | $10.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $51.24M 10-K · filed 2022-05-31 |
| 2019-12-31 | $2.45M 10-Q · filed 2021-02-09 | $65.56M derived: sum of 4 quarters · filed 2021-05-28 |
| 2019-09-30 | $22.98M 10-Q · filed 2020-11-06 | $63.46M derived: sum of 4 quarters · filed 2021-05-28 |
| 2019-06-30 | $14.89M 10-Q · filed 2020-08-07 | $62.54M derived: sum of 4 quarters · filed 2021-05-28 |
| 2019-03-31 | $25.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $81.49M 10-K · filed 2021-05-28 |
| 2018-12-31 | $354.00K 10-Q · filed 2020-02-10 | |
| 2018-09-30 | $22.06M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $33.84M 10-Q · filed 2019-08-07 | |
| 2018-03-31 | $65.48M 8-K · filed 2021-02-09 | |
| 2017-03-31 | $97.51M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |